Schenk DB - Search Results

1

Hepatic (Na+,K+)-ATPase: a current view of its structure, function and localization in rat liver as revealed by studies with monoclonal antibodies.

Leffert HL, Schenk DB, Hubert JJ, Skelly H, Schumacher M, Ariyasu R, Ellisman M, Koch KS, Keller GA. Leffert HL, et al. Among authors: schenk db. Hepatology. 1985 May-Jun;5(3):501-7. doi: 10.1002/hep.1840050327. Hepatology. 1985. PMID: 2987099 No abstract available.

2

Rat hepatic (Na+, K+)-ATPase: alpha-subunit isolation by immunoaffinity chromatography and structural analysis by peptide mapping.

Hubert JJ, Schenk DB, Skelly H, Leffert HL. Hubert JJ, et al. Among authors: schenk db. Biochemistry. 1986 Jul 15;25(14):4156-63. doi: 10.1021/bi00362a025. Biochemistry. 1986. PMID: 3017414

3

Use of a monoclonal antibody to quantify (Na+,K+)-ATPase activity and sites in normal and regenerating rat liver.

Schenk DB, Hubert JJ, Leffert HL. Schenk DB, et al. J Biol Chem. 1984 Dec 10;259(23):14941-51. J Biol Chem. 1984. PMID: 6094583 Free article.

4

(Na+,K+)-ATPase: a new assay of Na+-ATPase reveals covert anti-pump antibodies.

Schenk DB, Grosse R, Ellisman MH, Bradshaw V, Leffert HL. Schenk DB, et al. Anal Biochem. 1982 Sep 1;125(1):189-96. doi: 10.1016/0003-2697(82)90401-8. Anal Biochem. 1982. PMID: 6128943 No abstract available.

5

Monoclonal antibodies to rat Na+,K+-ATPase block enzymatic activity.

Schenk DB, Leffert HL. Schenk DB, et al. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5281-5. doi: 10.1073/pnas.80.17.5281. Proc Natl Acad Sci U S A. 1983. PMID: 6310568 Free PMC article.

6

Inhibitory monoclonal antibodies against rat liver alcohol dehydrogenase.

Lad PJ, Schenk DB, Leffert HL. Lad PJ, et al. Among authors: schenk db. Arch Biochem Biophys. 1984 Dec;235(2):589-95. doi: 10.1016/0003-9861(84)90233-9. Arch Biochem Biophys. 1984. PMID: 6393880

7

Sickle cell disease in Germany: Results from a national registry.

Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, Beier R, Schenk D, Schneider D, Groß-Wieltsch U, Prokop A, Heine S, Khurana C, Erlacher M, Dürken M, Linke C, Frühwald M, Corbacioglu S, Claviez A, Metzler M, Ebinger M, Full H, Wiesel T, Eberl W, Reinhard H, Tagliaferri L, Allard P, Karapanagiotou-Schenkel I, Rother LM, Beck D, Le Cornet L, Kulozik AE; German Sickle Cell Disease Registry. Kunz JB, et al. Pediatr Blood Cancer. 2020 Apr;67(4):e28130. doi: 10.1002/pbc.28130. Epub 2019 Dec 22. Pediatr Blood Cancer. 2020. PMID: 31867835

8

A giant GTPase, very large inducible GTPase-1, is inducible by IFNs.

Klamp T, Boehm U, Schenk D, Pfeffer K, Howard JC. Klamp T, et al. J Immunol. 2003 Aug 1;171(3):1255-65. doi: 10.4049/jimmunol.171.3.1255. J Immunol. 2003. PMID: 12874213

9

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.

Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG. Jankovic J, et al. Among authors: schenk db. JAMA Neurol. 2018 Oct 1;75(10):1206-1214. doi: 10.1001/jamaneurol.2018.1487. JAMA Neurol. 2018. PMID: 29913017 Free PMC article. Clinical Trial.

10

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.

Schenk DB, Koller M, Ness DK, Griffith SG, Grundman M, Zago W, Soto J, Atiee G, Ostrowitzki S, Kinney GG. Schenk DB, et al. Mov Disord. 2017 Feb;32(2):211-218. doi: 10.1002/mds.26878. Epub 2016 Nov 25. Mov Disord. 2017. PMID: 27886407 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters